Driehaus Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-292,292
| Closed | -$9.96M | – | 372 |
|
|
2022
Q1 | $9.96M | Sell |
292,292
-223,197
| -43% | -$7.6M | 0.12% | 233 |
|
|
2021
Q4 | $19.9M | Sell |
515,489
-35,576
| -6% | -$1.37M | 0.2% | 150 |
|
|
2021
Q3 | $29.8M | Sell |
551,065
-34,246
| -6% | -$1.85M | 0.35% | 85 |
|
|
2021
Q2 | $19.6M | Buy |
585,311
+236,471
| +68% | +$7.91M | 0.26% | 132 |
|
|
2021
Q1 | $7.19M | Sell |
348,840
-44,375
| -11% | -$914K | 0.11% | 247 |
|
|
2020
Q4 | $6.89M | Sell |
393,215
-8,548
| -2% | -$150K | 0.11% | 215 |
|
|
2020
Q3 | $5.96M | Buy |
401,763
+281,763
| +235% | +$4.18M | 0.12% | 189 |
|
|
2020
Q2 | $1.56M | Buy |
+120,000
| New | +$1.56M | 0.04% | 269 |
|
|
2015
Q3 | – | Sell |
-852
| Closed | -$322K | – | 506 |
|
|
2015
Q2 | $322K | Sell |
852
-643
| -43% | -$243K | 0.01% | 471 |
|
|
2015
Q1 | $625K | Buy |
+1,495
| New | +$625K | 0.02% | 441 |
|
|
2014
Q1 | – | Sell |
-21,275
| Closed | -$7.73M | – | 506 |
|
|
2013
Q4 | $7.73M | Sell |
21,275
-298
| -1% | -$108K | 0.28% | 104 |
|
|
2013
Q3 | $11.5M | Buy |
+21,573
| New | +$11.5M | 0.44% | 53 |
|